Attenuating Atherosclerosis through Inhibition of the NF-<i>κ</i>B/NLRP3/IL-1<i>β</i> Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)

<div>A graphic illustration of the mechanism action of Res, MCC950, and P53 in AS-associated VC.</div>

Cardiovascular Therapeutics

fig9

Figure 9

Figure 9: Attenuating Atherosclerosis through Inhibition of the NF-<i>κ</i>B/NLRP3/IL-1<i>β</i> Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs) 

Figure 9 | Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs) 